Update shared on06 Aug 2025
Fair value Increased 5.54%Analysts have raised KKR's price target to $162.30, citing long-term growth opportunities in private wealth, credit, and insurance, improved macro conditions, and sector-wide optimism, despite some caution from bearish analysts regarding near-term performance.
Analyst Commentary
- Bullish analysts cite long-term structural growth opportunities in private wealth, credit, insurance, and capital markets as attractive drivers for KKR.
- Improved macroeconomic backdrop, including tariff de-escalation, equity market rally, and normalized volatility, is seen as supportive of capital markets recovery, benefiting KKR.
- KKR’s shares have underperformed year-to-date, creating a potential rebound opportunity according to bullish analysts.
- Recent adjustments to estimates across the alternative asset manager sector reflect increased optimism for fundamental trends in KKR's business lines.
- Bearish analysts express more measured near-term expectations, prompting a downgrade to Hold and a lower relative price target.
What's in the News
- KKR completed a share buyback, repurchasing 1,000,000 shares for $110 million, totaling 68.3 million shares (13.18%) for $1.94 billion under its 2015 buyback program.
- KKR and Capital Group are expanding their partnership to launch a U.S. public-private equity interval fund, aiming for a 2026 launch, to provide diversified access to public and private equity markets.
- KKR and Energy Capital Partners launched a $4 billion, 190MW data center campus in Texas, their first major U.S. AI infrastructure project through a $50 billion strategic partnership.
- KKR committed AUD 500 million to partner with CleanPeak Energy, supporting the growth of Australia's distributed solar and battery storage sector as part of its Global Climate Transition strategy.
- KKR is involved in multiple high-profile M&A discussions and bids, including: advanced talks to acquire ST Telemedia Global Data Centres, interest in Sensa Core Medical Instrumentation and Harley-Davidson’s financing unit, a potential acquisition of Italian healthcare firm GPI, attempts to exit JB Chemicals, and participation in possible deals across China (Dayao), New Zealand (Spark, Ritchies Transport), Japan (Taiyo Holdings, Sapporo Real Estate), Vietnam (Vinschool), and India (Relisys Medical Devices).
Valuation Changes
Summary of Valuation Changes for KKR
- The Consensus Analyst Price Target has risen from $154.47 to $162.30.
- The Discount Rate for KKR has risen from 8.55% to 9.05%.
- The Consensus Revenue Growth forecasts for KKR has risen slightly from -14.6% per annum to -14.0% per annum.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.